Stuart Walter Peltz - 11 Jun 2021 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role: Chief Executive Officer, Director
Signature: /s/ Avraham S. Adler, attorney-in-fact
Issuer symbol: PTCT
Transactions as of: 11 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 11 Jun 2021, 18:20:54 UTC
Next filing: 06 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTCT	Common Stock	Award	$0	+6,240	+38%	$0.000000	22,721	11 Jun 2021	By Spouse	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PTCT	Stock Option (Right to Buy)	Award	$0	+36,400		$0.000000	36,400	11 Jun 2021	Common Stock	36,400	$42.95	By Spouse	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted on June 11, 2021 that vest in four equal installments over four years, commencing on June 11, 2022.
F2	This option was granted on June 11, 2021, and vests over four years, with 25% of the shares underlying the option vesting on June 11, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on September 11, 2022.